Ivonescimab + Chemo Outperforms PD-1 Combo in 1L Squamous NSCLC in Akeso’s HARMONi-6 Study Summit Therapeutics Inc. (NASDAQ: SMMT) has announced that Akeso, Inc. (HKEX: 9926.HK) has successfully met the…
Epicrispr & Springbok Partner on AI Muscle Analysis for First FSHD Human Study Epicrispr Biotechnologies, a company dedicated to developing curative gene-modulating therapies, has announced a strategic partnership with Springbok…
Innate Pharma Reclaims CD123 ANKET® Rights, Sanofi Plans Strategic Investment Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a clinical-stage biotechnology company specializing in immunotherapies for cancer, has announced significant…
Metro Biotech Begins Phase 1a Trial Dosing for NAD Booster MIB-725 Metro International Biotech, LLC (MetroBiotech), a member of the EdenRoc Sciences family focused on developing advanced therapies for age-related…
Vizgen Unveils MERFISH 2.0 and Enhanced OmniVUE Panels with ADC Biomarkers Vizgen, Inc., a pioneer in spatial genomics and proteomics, has announced the global commercial launch of MERFISH 2.0™, a…
New Algorithm Enables Near T2T Assembly with Standard ONT Simplex Reads A newly published study on bioRxiv introduces hifiasm-ONT, a groundbreaking genome assembly algorithm that enables partially phased, near telomere-to-telomere…
BigHat Biosciences and Lilly Partner on AI-Driven Antibody Therapeutics BigHat Biosciences, a pioneering biotechnology company leveraging machine learning (ML) to guide antibody discovery and development, has announced a strategic collaboration…
Thermo Fisher Opens San Diego Center to Boost Cell Therapy Development Thermo Fisher Scientific Inc., the global leader in serving science, has officially opened its Advanced Therapies Collaboration Center (ATxCC)…
Artedrone’s SASHA Robot Shows Autonomous Stroke Clot Removal in Preclinical Studies Artedrone, a medical technology company backed by Truffle Capital, has announced promising preclinical results for its innovative SASHA micro-robot—an…
ACIP Expands Pfizer’s RSV Vaccine Recommendation to At-Risk Adults 50–59 Pfizer Inc. (NYSE: PFE) announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
GC Therapeutics Adds Industry Veterans Kai-Hsin Chang and Azadeh Golipour to Leadership Team GC Therapeutics (GCTx), a trailblazing biotechnology company advancing innovative induced pluripotent stem cell (iPSC)-based therapies, today announced…
ABEC Unveils Breakthrough Single-Use Bioreactor for Cell Therapy ABEC, a global leader in engineering and manufacturing solutions for the biotechnology industry, has announced the launch of its Advanced Therapy Bioreactor…